Search

Search Results
Results 12011 - 12020 of 12020 for Placebo
  • Drug - 1 May 2025
    Consumer Medicine Information (CMI) about Zeldox Capsules intended for persons living in Australia.
  • Drug - 10 Mar 2025
    Consumer Medicine Information (CMI) about Allertine intended for persons living in Australia.
  • Drug - 24 Feb 2025
    Consumer Medicine Information (CMI) about Xtandi intended for persons living in Australia.
  • Drug - 23 Feb 2024
    Consumer Medicine Information (CMI) about Mizart HCT (New) (Telmisartan and Hydrochlorothiazide) intended for persons living in Australia.
  • Drug - 24 Mar 2023
    Consumer Medicine Information (CMI) about Galantyl (galantamine) intended for persons living in Australia.
  • News - 18 Sep 2012
    Pfizer Inc. announced today that 14 abstracts for tofacitinib, an investigational oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis...
  • News - 4 May 2012
    Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter 2012, and company highlights.
  • News - 25 Jul 2012
    Elan Corporation, plc today reported its second quarter and first half 2012 financial results.
  • News - 18 Feb 2010
    Incyte Corporation today reported fourth quarter and full year 2009 financial results, provided an update on key fourth quarter accomplishments and 2010 objectives, and announced its 2010 financial...
  • Supplier - 26 Sep 2020
    Atlantia Clinical Trials Ltd is a CRO that specializes in conducting studies in foods, beverages and supplements for companies world-wide.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.